Consequently, DNAH5 might be a biomarker that could guide the diagnosis and therapy of HCC, and it is necessary that further studies validating the prognosis value of DNAH5 in HCC are conducted. The gene discussed is DNAH5; the disease is hepatocellular carcinoma.